BANGKOK, June 4, 2026 /PRNewswire/ -- Delta Electronics (Thailand) Public Company Limited, a global leader in power management and smart green solutions, is presenting...
Securing this CE mark expands access to the HydroMARK™ Plus markers across Europe, combining proprietary hydrogel technology with features designed to support marker stability...
SINGAPORE, June 4, 2026 /PRNewswire/ -- Synology is unveiling its latest innovations at COMPUTEX 2026, featuring a comprehensive portfolio of AI-enhanced solutions spanning the...
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.
New GeneSight ® Mental Health Monitor Reveals 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
New GeneSight ® Mental Health Monitor Reveals 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
TAIPEI , June 3, 2026 /PRNewswire/ -- NVIDIA GTC -- GMI Cloud, an AI-native cloud infrastructure company purpose-built for production AI, today announced its support for...
VALENCIA, Calif., June 3, 2026 /PRNewswire/ -- Sunkist Growers unveiled a refreshed Sunkist.com experience, introducing a bold new digital platform built around a simple...
Purpose-built for law enforcement, legal, government, healthcare, and financial services, VIDIZMO AI Intelligence Hub analyzes video, audio, documents, and images together, on your private...